Lundquist Institute Investigators Co-Author Paper in JAMA on Coronary Heart Dis…
Friday, June 2, 2023
Drs. Jerome Rotter & Matt Budoff Study Shows that in Middle-aged to Older Adults the Coronary Artery Calcium Score Improved CHD Risk Discrimination
Lundquist Investigator Dr. Marc Swidergall’s Paper Published in Nature Communic…
IL-23 receptor signaling prevents ferroptotic cell death via an unknown mechanism.
4HNE released by ferroptotic macrophages induces apoptosis, ferroptosis, necroptosis, and pyroptosis in adjacent cells.
Lundquist Investigator Dr. Denise Al Alam Wins the ATS Assembly on Pediatrics M…
ATS (American Thoracic Society) gives this award to a mid-career candidate who is recognized for achievements in research, mentorship, clinical care, education, advocacy, or scholarship.
Dr. Al Alam received this award as a recognition for her numerous contributions to pediatric pulmonary research, mentorship and advocacy.
The Lundquist Institute (TLI) Receives Grant from the Johnny Carson Foundation …
Funding will be directed to TLI’s Institute of Respiratory Medicine and Exercise Physiology with a Research Focus on Diverse and Underserved Patient Populations
The Lundquist Institute has announced that it has received a grant of $112,000 from the Johnny Carson Foundation to support the training of the next generation of chronic obstructive pulmonary disease (COPD) researchers.
Lundquist Investigator Eiji Yoshihara, Ph.D., Receives Grant to Explore Potenti…
Beatson Foundation award may help develop a novel technology to generate an infinite supply of insulin producing cells
Eiji Yoshihara, Ph.D., Investigator at The Lundquist Institute, has received a two-year, $220,000 grant from the Beatson Foundation for a proposed study to investigate how human pancreatic β cells, responsible for making insulin in the body.
International Multi-institutional Collab Unveils Molecular Basis of Pancreatitis
April 28, 2022
Scientists from 13 different institutions including The Lundquist Institute in 4 different countries (USA, Korea, Japan, Australia) teamed up for a multi-institutional study on the molecular basis of pancreatitis.
Participants Needed for Healthy Controls Study
April 26, 2022
We are doing this study to find out why kids with MPS have problems with their bones, joints, brains, and other parts of their body so we can come up with medications that help them.
Lundquist Institute Investigator Dr. Frans Walther Receives Grant to Develop an…
April 11, 2022
The non-invasive delivery device will be for use in respiratory distress syndrome (RDS), a significant cause of neonatal mortality and morbidity
Lundquist Institute Investigator Eiji Yoshihara, PhD., Receives Internationally…
April 11, 2022
JDRF Career Development Awards are highly competitive and given to only a few promising junior researchers each year
Eli Ipp, MD, is Lead Author on a JAMA Open Network Study that Positively Evalua…
November 19, 2021
The study examines performance of the EyeArt AI system for detecting eyes with more than mild diabetic retinopathy (mtmDR) and vision-threatening diabetic retinopathy (vtDR).
Investigator Aims to Improve Stroke Recovery with New Granular Biomaterials
Research is funded by five-year, $2.29 million grant from the National Institute of Neurological Disorders and Stroke
A grant from the NIH to explore the use of injectable porous biomaterials to target post-stroke immune response and promote new blood vessel and axon formation.
Lundquist Institute Investigators Develop a Significant Novel Mouse Model of th…
November 19, 2021
Ataxia Telangiectasia (A-T) Is a Devastating Disorder in Children Characterized by a Severe Loss of Motor Coordination (Ataxia), Increased Cancer Susceptibility, Immunodeficiency, and Premature Death
Early Use of Convalescent Plasma for COVID-19 Disease Progression
Use Does Not Prevent COVID-19 Disease Progression
Investigators at The Lundquist Institute and research colleagues at other institutions have found that passive immunization is not a viable strategy .
The Lundquist Institute Receives $3 Million From NIH to Expand Male Contracepti…
November 2, 2021
The Lundquist Institute’s Male Contraceptive Efficacy Trial has received an additional $3 million from the National Institutes of Health (NIH) to expand its work and recruit 120+ more couples.
New Promising Compound for Male Contraceptive Pill
Non-hormonal compound purified from Chinese herb
Institute researchers discovered a natural compound that exhibits almost ideal male contraceptive effects in pre-clinical studies.
Longstanding Fallopian Tube Transport Debate
A group of investigators led by The Lundquist Institute's Wei Yan, MD, PhD demonstrated that motile cilia in the Fallopian tube are essential for oocyte pickup.